Introduction
Methamphetamine (MA) is one of the most commonly abused illicit psychostimulant drugs.1 MA user disorder is associated with paranoia, behavioural impulsivity and cognitive impairment.2 However, neither medication nor psychosocial treatment has been proven to effectively treat MA use disorder with regard to vulnerability for relapse.3 A number of factors are thought to contribute to relapse, including exposure to drug cues and addiction severity.4 Drug cues refer to things, people or situations that are associated with drug use, which may trigger drug seeking behavior.5 Despite many intervention approaches to MA use disorder, the indicator of addiction severity is mainly limited to the subjective craving score to drug-related cues,6 7 which is obscured by many factors such as social approval and self-masking.8
Cognitive models, such as the expectancy model, the dual-affect model and the cognitive processing model, all hold that external environmental events serve as triggers for drug use.9 For an individual addicted to a specific substance, stimuli associated with that substance will automatically capture attention whereas this is not evident in normal subjects. It has been indicated that the attention bias (AB) towards drug-related cues has a predictive role for drug relapse10 and may be an important factor in predicting drug abuse treatment outcome.11 Attention bias for drug-related cues can be measured directly by monitoring eye movements,12 or indirectly inferred with reaction time or other indicators.13 14 Indirect measures of attentional bias have largely made use of either of two tasks: the modified Stroop task and visual probe (dot-probe) task.15 16 Attentional bias is indicated by faster reaction times to probes that replace drug-related images, which has been generally applied in tobacco, opiate and cocaine use disorder studies. However, few studies have focused on the attention bias of methamphetamine users.11 Although direct measurement of attention bias may be done using eye-tracking, simple measures may be preferred for practical purposes and ease of administration (such as the high cost of eye-tracking equipment).
Furthermore, as subjects do not need to overtly assess how they are craving for drug use, the attention bias test should be independent of subjects’ attitude towards MA use or sociocultural influences. Consideration of these potential obscuring factors is particularly important in assessing addiction severity in MA users, as MA use is illegal across the world. In this regard, attention bias to drug cues may be a more objective and sensitive index for addiction severity. Currently, we use a modified visual probe task, which employs attentional bias as an indicator, to test how attention bias to drug cues may predict addiction severity in MA users.
Specifically, this study directly compared the results of self-report craving and drug-related attention bias, and we examined whether self-reported craving for drug cues is a reliable index for the detection of addiction severity in subjects with a long history of MA use disorder, and then tested whether the severity of addiction can be more sensitively and reliably assessed by the cue-induced attention bias test.